{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T11:44:34Z","timestamp":1773143074280,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Istanbul University-Cerrahpasa Scientific Research Projects Coordination Unit","award":["TYO-2017-24271"],"award-info":[{"award-number":["TYO-2017-24271"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12026-025-09699-2","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:11:05Z","timestamp":1760094665000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Genomic and clinical characterization of adult CVID patients: results from a single-centre turkish cohort"],"prefix":"10.1007","volume":"73","author":[{"given":"Hulya","family":"Yilmaz Tekinhatun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sinem","family":"Firtina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muge","family":"Sayitoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0332-9253","authenticated-orcid":false,"given":"Muhlis Cem","family":"Ar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,10]]},"reference":[{"key":"9699_CR1","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s12026-007-0024-0","volume":"38","author":"C Cunningham-Rundles","year":"2007","unstructured":"Cunningham-Rundles C, Knight AK. Common variable immune deficiency: reviews, continued puzzles, and a new registry. Immunol Res. 2007;38:78\u201386. https:\/\/doi.org\/10.1007\/s12026-007-0024-0.","journal-title":"Immunol Res"},{"key":"9699_CR2","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1182\/hematology.2019002062","volume":"2019","author":"C Cunningham-Rundles","year":"2019","unstructured":"Cunningham-Rundles C. Common variable immune deficiency: case studies. Hematology. 2019;2019:449\u201356. https:\/\/doi.org\/10.1182\/hematology.2019002062.","journal-title":"Hematology"},{"key":"9699_CR3","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.jaci.2007.10.001","volume":"120","author":"L Zhang","year":"2007","unstructured":"Zhang L, Radigan L, Salzer U, et al. Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes. J Allergy Clin Immunol. 2007;120:1178\u201385. https:\/\/doi.org\/10.1016\/j.jaci.2007.10.001.","journal-title":"J Allergy Clin Immunol"},{"key":"9699_CR4","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jaci.2013.12.1077","volume":"134","author":"B Gathmann","year":"2014","unstructured":"Gathmann B, Mahlaoui N, G\u00e9rard L, et al. Clinical picture and treatment of 2212 patients with common variable immunodeficiency. J Allergy Clin Immunol. 2014;134:116\u201326. https:\/\/doi.org\/10.1016\/j.jaci.2013.12.1077.","journal-title":"J Allergy Clin Immunol"},{"key":"9699_CR5","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1182\/blood-2007-11-124545","volume":"112","author":"H Chapel","year":"2008","unstructured":"Chapel H, Lucas M, Lee M, et al. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood. 2008;112:277\u201386. https:\/\/doi.org\/10.1182\/blood-2007-11-124545.","journal-title":"Blood"},{"key":"9699_CR6","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1182\/blood-2011-09-377945","volume":"119","author":"ES Resnick","year":"2012","unstructured":"Resnick ES, Moshier EL, Godbold JH, Cunningham-Rundles C. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood. 2012;119:1650\u20137. https:\/\/doi.org\/10.1182\/blood-2011-09-377945.","journal-title":"Blood"},{"key":"9699_CR7","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1146\/annurev-pathmechdis-031521-024229","volume":"18","author":"XP Peng","year":"2023","unstructured":"Peng XP, Caballero-Oteyza A, Grimbacher B. Common variable immunodeficiency: more pathways than roads to Rome. Annu Rev Pathol. 2023;18:283\u2013310. https:\/\/doi.org\/10.1146\/annurev-pathmechdis-031521-024229.","journal-title":"Annu Rev Pathol"},{"key":"9699_CR8","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/imr.12728","volume":"287","author":"C Cunningham-Rundles","year":"2019","unstructured":"Cunningham-Rundles C. Common variable immune deficiency: dissection of the variable. Immunol Rev. 2019;287:145\u201361. https:\/\/doi.org\/10.1111\/imr.12728.","journal-title":"Immunol Rev"},{"key":"9699_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00220","volume":"7","author":"P Maffucci","year":"2016","unstructured":"Maffucci P, Filion CA, Boisson B, et al. Genetic diagnosis using whole exome sequencing in common variable immunodeficiency. Front Immunol. 2016;7:220. https:\/\/doi.org\/10.3389\/fimmu.2016.00220.","journal-title":"Front Immunol"},{"key":"9699_CR10","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1006\/clim.1999.4799","volume":"93","author":"ME Conley","year":"1999","unstructured":"Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (pan-american group for immunodeficiency) and ESID (european society for immunodeficiencies). Clin Immunol. 1999;93:190\u20137. https:\/\/doi.org\/10.1006\/clim.1999.4799.","journal-title":"Clin Immunol"},{"key":"9699_CR11","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s12026-021-09248-7","volume":"70","author":"S Firtina","year":"2022","unstructured":"Firtina S, Ng YY, Ng OH, et al. Primary antibody deficiencies in Turkey: molecular and clinical aspects. Immunol Res. 2022;70:134. https:\/\/doi.org\/10.1007\/s12026-021-09248-7.","journal-title":"Immunol Res"},{"key":"9699_CR12","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201324. https:\/\/doi.org\/10.1038\/gim.2015.30.","journal-title":"Genet Med"},{"key":"9699_CR13","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/cge.14516","volume":"106","author":"P Stawi\u0144ski","year":"2024","unstructured":"Stawi\u0144ski P, P\u0142oski R. Genebe.net: implementation and validation of an automatic ACMG variant pathogenicity criteria assignment. Clin Genet. 2024;106:119\u201326. https:\/\/doi.org\/10.1111\/cge.14516.","journal-title":"Clin Genet"},{"key":"9699_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-024-01664-2","volume":"44","author":"A Segura-Tudela","year":"2024","unstructured":"Segura-Tudela A, L\u00f3pez-Nevado M, Nieto-L\u00f3pez C, et al. Enrichment of immune dysregulation disorders in adult patients with human inborn errors of immunity. J Clin Immunol. 2024;44:61. https:\/\/doi.org\/10.1007\/s10875-024-01664-2.","journal-title":"J Clin Immunol"},{"key":"9699_CR15","doi-asserted-by":"publisher","DOI":"10.70962\/jhi.20250002","volume":"1","author":"AA Bousfiha","year":"2025","unstructured":"Bousfiha AA, Jeddane L, Moundir A, et al. The 2024 update of IUIS phenotypic classification of human inborn errors of immunity. Journal of Human Immunity. 2025;1:e20250002. https:\/\/doi.org\/10.70962\/jhi.20250002.","journal-title":"Journal of Human Immunity"},{"key":"9699_CR16","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/MOP.0000000000001315","volume":"36","author":"JE Yu","year":"2024","unstructured":"Yu JE. New primary immunodeficiencies 2023 update. Curr Opin Pediatr. 2024;36:112\u201323. https:\/\/doi.org\/10.1097\/MOP.0000000000001315.","journal-title":"Curr Opin Pediatr"},{"key":"9699_CR17","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.jaci.2014.04.042","volume":"134","author":"H Abolhassani","year":"2014","unstructured":"Abolhassani H, Wang N, Aghamohammadi A, et al. A hypomorphic recombination-activating gene 1 (RAG1) mutation resulting in a phenotype resembling common variable immunodeficiency. J Allergy Clin Immunol. 2014;134:1375\u201380. https:\/\/doi.org\/10.1016\/j.jaci.2014.04.042.","journal-title":"J Allergy Clin Immunol"},{"key":"9699_CR18","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1182\/blood-2010-02-267583","volume":"116","author":"SS De Ravin","year":"2010","unstructured":"De Ravin SS, Cowen EW, Zarember KA, et al. Hypomorphic Rag mutations can cause destructive midline granulomatous disease. Blood. 2010;116:1263\u201371. https:\/\/doi.org\/10.1182\/blood-2010-02-267583.","journal-title":"Blood"},{"key":"9699_CR19","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.17056.1","author":"A Gennery","year":"2019","unstructured":"Gennery A. Recent advances in understanding RAG deficiencies. F1000Res. 2019. https:\/\/doi.org\/10.12688\/f1000research.17056.1.","journal-title":"F1000Res"},{"key":"9699_CR20","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.152186","author":"X Zhang","year":"2022","unstructured":"Zhang X, Moore CM, Harmacek LD. Cftr-mediated monocyte\/macrophage dysfunction revealed by cystic fibrosis proband-parent comparisons. JCI Insight. 2022. https:\/\/doi.org\/10.1172\/jci.insight.152186.","journal-title":"JCI Insight"},{"key":"9699_CR21","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/s41375-018-0074-4","volume":"32","author":"J Davidsson","year":"2018","unstructured":"Davidsson J, Puschmann A, Tedg\u00e5rd U, Bryder D, Nilsson L, Cammenga J. SAMD9 and SAMD9L in inherited predisposition to ataxia, pancytopenia, and myeloid malignancies. Leukemia. 2018;32:1106\u201315. https:\/\/doi.org\/10.1038\/s41375-018-0074-4.","journal-title":"Leukemia"},{"key":"9699_CR22","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.imbio.2006.11.014","volume":"212","author":"Y Endo","year":"2007","unstructured":"Endo Y, Matsushita M, Fujita T. Role of ficolin in innate immunity and its molecular basis. Immunobiology. 2007;212:371\u20139. https:\/\/doi.org\/10.1016\/j.imbio.2006.11.014.","journal-title":"Immunobiology"},{"key":"9699_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2021.104335","volume":"64","author":"M Alstrup","year":"2021","unstructured":"Alstrup M, Marks SD, Ek J, et al. First patient with ILNEB syndrome due to pathogenic variants in ITGA3 surviving to adulthood. Eur J Med Genet. 2021;64:104335. https:\/\/doi.org\/10.1016\/j.ejmg.2021.104335.","journal-title":"Eur J Med Genet"},{"key":"9699_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-016-0514-z","volume":"11","author":"EA Colombo","year":"2016","unstructured":"Colombo EA, Spaccini L, Volpi L, et al. Viable phenotype of ILNEB syndrome without nephrotic impairment in siblings heterozygous for unreported integrin alpha3 mutations. Orphanet J Rare Dis. 2016;11:136. https:\/\/doi.org\/10.1186\/s13023-016-0514-z.","journal-title":"Orphanet J Rare Dis"},{"key":"9699_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02325","volume":"10","author":"F Rudilla","year":"2019","unstructured":"Rudilla F, Franco-Jarava C, Mart\u00ednez-Gallo M, et al. Expanding the clinical and genetic spectra of primary immunodeficiency-related disorders with clinical exome sequencing: expected and unexpected findings. Front Immunol. 2019;10:2325. https:\/\/doi.org\/10.3389\/fimmu.2019.02325.","journal-title":"Front Immunol"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-025-09699-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-025-09699-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-025-09699-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T07:29:07Z","timestamp":1770190147000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-025-09699-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,10]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["9699"],"URL":"https:\/\/doi.org\/10.1007\/s12026-025-09699-2","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,10]]},"assertion":[{"value":"10 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine (Approval Date: March 1, 2016; Approval Number: A-61). Written informed consents were obtained from patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"141"}}